Thomas Crabbe
Impact in
- Cancer Research top 1%
- Protease and Inhibitor Mechanisms
- Hematology top 1%
- Blood Coagulation and Thrombosis Mechanisms
Papers in
-
- Protease and Inhibitor Mechanisms 15
- Oncology 12
- Peptidase Inhibition and Analysis 12
- Co-authors
- Gillian Murphy (7 shared papers)Andrew Docherty (10 shared papers)Susan J. Atkinson (3 shared papers)Michael J. Butler (2 shared papers)James P. O’Connell (6 shared papers)Frances Willenbrock (4 shared papers)Georgina S. Butler (2 shared papers)Marie‐Pia d’Ortho (1 shared paper)
- Journals
- Biochemistry (4 papers)FEBS Letters (3 papers)Journal of Biological Chemistry (2 papers)Alcohol and Alcoholism (1 paper)Biochemical Society Transactions (1 paper)
- Partner nations
- United KingdomChinaCanada
In The Last Decade
Thomas Crabbe
20 papers receiving 2.1k citations
Thomas Crabbe's Hit Papers
Peers
Comparison fields: 5 of 96
- Cancer Research 1.4k
- Hematology 621
- Immunology and Allergy 304
- Oncology 892
- Biotechnology 108
Countries citing papers authored by Thomas Crabbe
This map shows the geographic impact of Thomas Crabbe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Crabbe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Crabbe more than expected).
Fields of papers citing papers by Thomas Crabbe
This network shows the impact of papers produced by Thomas Crabbe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Crabbe. The network helps show where Thomas Crabbe may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Crabbe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The TIMP2 Membrane Type 1 Metalloproteinase “Receptor” Regulates the Concentration and Efficient Activation of Progelatinase A Hit paper breakdown → | 1998 | 511 |
| 2 | 1995 | 217 | |
| 3 | 1993 | 206 | |
| 4 | 1994 | 185 | |
| 5 | 1995 | 163 | |
| 6 | 2007 | 123 | |
| 7 | Matrix metalloproteinases and metastatic cancer. | 1998 | 108 |
| 8 | 1993 | 90 | |
| 9 | 1994 | 82 | |
| 10 | 1994 | 82 | |
| 11 | 1996 | 75 | |
| 12 | 1992 | 75 | |
| 13 | 1994 | 59 | |
| 14 | 2005 | 54 | |
| 15 | 1998 | 23 | |
| 16 | 2003 | 22 | |
| 17 | 1996 | 18 | |
| 18 | 2007 | 11 | |
| 19 | 1995 | 10 | |
| 20 | 1996 | 6 |
About Thomas Crabbe
Thomas Crabbe is a scholar working on Cancer Research, Oncology, Hematology, Molecular Biology and Biotechnology, having authored 20 papers that have together received 2.1k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (15 papers), Peptidase Inhibition and Analysis (12 papers), Blood Coagulation and Thrombosis Mechanisms (8 papers), Enzyme Production and Characterization (4 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Enzyme Catalysis and Immobilization (1 paper), Phosphodiesterase function and regulation (1 paper) and Cholinesterase and Neurodegenerative Diseases (1 paper). The work is most often cited by research in Cancer Research (1.4k citations), Hematology (621 citations), Immunology and Allergy (304 citations), Oncology (892 citations) and Biotechnology (108 citations). Thomas Crabbe has collaborated with scholars based in United Kingdom, China and Canada. Frequent co-authors include Gillian Murphy, Andrew Docherty, Susan J. Atkinson, Michael J. Butler, James P. O’Connell, Frances Willenbrock, Georgina S. Butler, Marie‐Pia d’Ortho, Tatsuya Tamura and John M. Clements. Their work appears in journals such as Biochemistry, FEBS Letters, Journal of Biological Chemistry, Alcohol and Alcoholism and Biochemical Society Transactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.